Pneumothorax in pulmonary langerhans cell histiocytosis

Chest

Volumn 125, Issue 3, 2004, Pages 1028-1032

  Mendez, Jose L ^a   Nadrous, Hassan F ^a   Vassallo, Robert ^a   Decker, Paul A ^a   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Histiocytosis X; Langerhans cell histiocytosis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTIOCYTOSIS; HUMAN; INCIDENCE; LANGERHANS CELL; LUNG ALVEOLUS CELL; LUNG FUNCTION; LUNG SURGERY; MALE; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY LANGERHANS CELL HISTIOCYTOSIS; RECURRENT DISEASE; SURVIVAL RATE;

EID: 1642320261     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.1028     Document Type: Article

References (32)

1. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000; 342:1969-1978
2. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax 2000; 55:405-416
3. Ryu JH, Colby TV, Hartman TE, et al. Smoking-related interstitial lung diseases: concise review. Eur Respir J 2001; 17:122-132
4. Smets A, Mortele K, de Praeter G, et al. Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis. Pediatr Radiol 1997; 27:873-876
5. Nagai S, Hoshino Y, Hayashi M, et al. Smoking-related interstitial lung diseases. Curr Opin Pulm Med 2000; 6:415-419
6. Vassallo R, Ryu JH, Schroeder D, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002; 346:484-490
7. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17:971-986
8. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary pulmonary histiocytosis in the adult. Medicine (Baltimore) 1981; 60:385-396
9. Crausman RS, Jennings CA, Tuder RM, et al. Pulmonary histiocytosis X: pulmonary function and exercise physiology. Am J Respir Crit Care Med 1996; 153:426-435
10. Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Eur Respir J 1996; 9:2002-2006
11. Schönfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993; 60:38-44
12. Flume PA. Pneumothorax in cystic fibrosis. Chest 2003; 123:217-221
13. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. JAMA 1958; 53:457-481
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170
15. Soler P, Bergeron A, Kambouchner M, et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med 2000; 162:264-270
16. Basset F, Corrin B, Spencer H, et al. Pulmonary histiocytosis X. Am Rev Respir Dis 1978; 118:811-820
17. Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis Am J Respir Crit Care Med 2002; 166:1483-1490
18. Light RW. Pneumothorax. In: Pleural diseases. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2001; 284-319
19. Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med 2000; 342:868-874
20. Light RW, O'Hara VS, Moritz TE, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. JAMA 1990; 264:2224-2230
21. Melton LJ III, Hepper NGG, Offord KP. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis 1979; 120:1379-1382
22. Dines DE, Clagett OT, Payne WS. Spontaneous pneumothorax in emphysema. Mayo Clin Proc 1970; 45:481-487
23. Afessa B. Pleural effusions and pneumothoraces in AIDS. Curr Opin Pulm Med 2001; 7:202-209
24. Aktogu S, Yorgancioglu A, Cirak K, et al. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J 1996; 9:2031-2035
25. Taylor JR, Ryu JH, Colby TV, et al. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990; 323:1254-1260
26. Kitaichi M, Nishimura K, Itoh H, et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151:527-533
27. Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115:1041-1052
28. Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis: a study of 69 patients. Medicine (Baltimore) 1999; 78:321-337
29. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55:1052-1057
30. Schramel FMNH, Postmus PE, Vanderschueren RGJRA. Current aspects of spontaneous pneumothorax. Eur Respir J 1997; 10:1372-1379
31. Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119: 590-602
32. Yankaskas JR, Mallory GB Jr, and the Consensus Committee. Lung transplantation in cystic fibrosis: consensus conference statement. Chest 1998; 113:217-226